Biocon Ltd.

₹350.7

18.2 (5.5%)

BIOCON Share Price

Pharmaceuticals & Biotechnology

As on October 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 57,039.3 Cr

P/E Ratio147.43

Dividend Yield0.03 %

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	333.15	Bullish
10-DMA	339.25	Bullish
20-DMA	350.31	Bullish
50-DMA	379.4	Bearish
100-DMA	401.09	Bearish
200-DMA	391.07	Bearish

Historical Performance

1 Year

-4.1%

3 Years

57.5%

5 Years

3.8%

10 Years

127.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Net Sales	1,69,270	1,52,617	1,47,557	1,11,742	81,840
Total Expenditure	1,35,854	1,22,430	1,15,590	90,547	66,914
Other Income	4,562	13,558	9,675	7,681	6,903
Operating Profit	37,978	43,745	41,642	28,876	21,829
Interest	9,903	8,974	9,744	4,190	676
Depreciation	19,567	16,870	15,688	11,131	8,142
Profit Before Tax	4,479	18,866	15,252	8,971	9,831
Consolidated Net Profit	3,856	10,133	10,225	4,627	6,484
Adjusted EPS	2	8	9	4	5

Compounded Sales Growth

10 Years:38.3

5 Years:18.8

3 Years:8.7

TTM:2.1

Compounded Profit Growth

10 Years:-6.9

5 Years:-12.2

3 Years:-3.6

TTM:-17.6

Stock Price CAGR

10 Years:8.6

5 Years:0

3 Years:16.3

TTM:-6.2

Return on Equity

10 Years:5.1

5 Years:5.4

3 Years:8.5

last year:2.4

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2026	Mar-2025	Mar-2024	Mar-2023	Mar-2022
Share Capital	8,105	6,003	6,003	6,003	6,003
Total Reserves	3,27,070	2,06,188	1,88,633	1,69,926	76,281
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	1,24,043	1,64,933	1,51,198	2,07,423	68,027
Other Current Liabilities	30,593	39,657	64,812	18,149	10,312
Short Term Borrowings	35,663	34,547	21,492	24,802	8,960
Total Liabilities	6,30,950	5,85,396	5,57,534	5,17,418	2,01,007
Capital Work in Progress	46,127	41,017	39,852	25,875	34,203
Long Term Loans & Advances	9,738	8,708	8,925	6,832	4,838
Currents Investments	6,898	4,473	3,156	13,265	12,177
Short Term Loans and Advances	8,047	9,170	10,960	4,564	4,005
Total Current Assets	1,71,798	1,62,862	1,51,792	1,23,340	83,823
Total Assets	6,30,950	5,85,396	5,57,534	5,17,418	2,01,007
Adjusted Book Value	207	177	162	147	69

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 147.43, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 16.5%, indicating sustained price appreciation.
The stock carries a low beta of 0.7, suggesting lower volatility than the broader market.
In the last financial year, the company reported an EBITDA of ₹37978 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹169270 million, indicating a large and established business.

Investment Calculator

Investment Amount:₹

Investment Amount: ₹ 1000000

Current Value: ₹ 938453.3

No. of Shares: 2676 (Approx)

Performance:-6.2%

-61546.7

NIFTY Performance: -12.9%

1 day Top Gainers